Recent investigations have implicated that eIF3a was upregulated in several solid tumors, such as urinary bladder cancer (UBC) and hepatocellular carcinoma (HCC) [11–13], eIF3a expression has been found to be associated with prognosis of tumor patients [12, 14]. The gene discussed is EIF3A; the disease is hepatocellular carcinoma.